Starpharma Holdings Ltd has released a press release.
VIRALEZE launches in Europe
Filed with ASX ·
6ix hasn’t read this filing yet.
Starpharma Holdings Limited on 6ix
Story so far
Earlier from Starpharma
- VIRALEZE™ now launched by LloydsPharmacy in the UK
- VIRALEZE to be launched with LloydsPharmacy in the UK
- DEP HER2-lutetium outperforms in human breast cancer model
- VIRALEZE antiviral nasal spray registered in Europe
- Starpharma signs DEP ADC Research Agreement with MSD
Later from Starpharma
- VIRALEZE SPL7013 highly active in UK variant of coronavirus
- VIRALEZE antiviral nasal spray registered for sale in India
- VIRALEZE SPL7013 virucidal against multiple COVID variants
- VIRALEZE UK Update
- VIRALEZE SPL7013 virucidal against SARS-CoV-2 Delta variant
Follow Starpharma into a list and get an email when it puts out news.
Follow Starpharma